J. Velden

发表

Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes

A. Hart, F. Kate, F. Lammes, 1997, Cancer.

Squamous cell carcinoma of the vulva with bulky positive groin nodes—nodal debulking versus full groin dissection prior to radiation therapy

N. Hacker, J. Velden, M. Schilthuis, 2006, International Journal of Gynecologic Cancer.

Chapter 6 – Controversies in Early Vulvar Cancer

J. Velden, 2004 .

Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival

F. Kate, A. Heintz, F. Lammes, 1995, Cancer.

Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I.

D. Provencher, K. Gaarenstroom, V. Zanagnolo, 2016, Gynecologic oncology.

Surgical interventions for early squamous cell carcinoma of the vulva.

J. Velden, 2000 .

Endometrial Stromal Sarcoma: Treatment and Patterns of Recurrence

M. Buist, J. Velden, 2009, International Journal of Gynecologic Cancer.

Evaluation of response to hormone therapy in patients with measurable adult granulosa cell tumors of the ovary

G. Kenter, M. Buist, J. Velden, 2015, Acta obstetricia et gynecologica Scandinavica.

General practice at work : its contribution to epidemiology and health policy

J. Velden, 1999 .

Results from neoadjuvant chemotherapy followed by surgery compared to chemoradiation for stage Ib2-IIb cervical cancer, EORTC 55994.

D. Katsaros, G. Kenter, I. Vergote, 2019, Journal of Clinical Oncology.

Morbidity of radical hysterectomy combined with caesarean section in pregnant patients with cervical cancer

R. Painter, J. Velden, C. Mom, 2021 .

Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix

R. Rietbroek, D. González, J. Dijk, 1997, Cancer.

Controversies in the Management of Advanced Vulvar Cancer

G. Thomas, E. Wiebe, J. Velden, 2014 .

Reaching the poor in Ghana's National Health Insurance Scheme: equity aspects and strategies to improve enrolment

R. Baltussen, E. Spaan, I. Agyepong, 2008 .

A phase 3 trial of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer.

N. Aaronson, K. Sikorska, A. Aalbers, 2017 .

The value of 3 . 0 Tesla diffusion-weighted MRI for pelvic nodal staging in patients with early stage cervical cancer

J. Stoker, P. Peeters, W. Veldhuis, 2012 .

Severe Pelvic Floor Symptoms After Cervical Cancer Treatment Are Predominantly Associated With Mental and Physical Well-Being and Body Image: A Cross-Sectional Study

M. Sprangers, J. Roovers, J. Velden, 2012, International Journal of Gynecologic Cancer.

Dutch national survey of general practice: morbidity in general practice.

F. Schellevis, A. Claessens, J. Velden, 1992 .

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†.

D. Timmerman, J. Ledermann, R. Glasspool, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Squamous cell cancer of the vulva with occult lymph node metastases in the groin: the impact of surgical technique on recurrence pattern and survival

F. Kate, J. Velden, M. Schilthuis, 2004, International Journal of Gynecologic Cancer.

Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I.

D. Provencher, H. V. van Doorn, G. D. de Bock, 2016, Gynecologic oncology.

Subsequent development of acute non‐lymphocytic leukemia in patients treated for Hodgkin's disease

A. Hagenbeek, W. van Putten, M. Durand, 1988, International journal of cancer.

Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix

E. Jordanova, G. Kenter, T. D. de Gruijl, 2016, Modern Pathology.

Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology.

B. Mol, F. Kate, O. Bleker, 1999, Gynecologic oncology.

Phase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancer.

R. Rietbroek, J. Dijk, A. Westermann, 2004, Gynecologic oncology.

Volume-controlled versus short drainage after inguinofemoral lymphadenectomy in vulvar cancer patients: A Dutch nationwide prospective study.

K. Gaarenstroom, J. Velden, B. Slangen, 2017, Gynecologic oncology.

Long-term cervical cancer survivors suffer from pelvic floor symptoms: a cross-sectional matched cohort study.

J. Roovers, C. H. van der Vaart, J. Velden, 2010, Gynecologic oncology.

The value of 3.0Tesla diffusion-weighted MRI for pelvic nodal staging in patients with early stage cervical cancer.

J. Stoker, P. Peeters, W. Veldhuis, 2012, European journal of cancer.

Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer.

N. Aaronson, K. Sikorska, K. K. van de Vijver, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy.

M. D. den Bakker, C. Burger, A. Ansink, 2007, Gynecologic oncology.

Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group).

I. Vergote, P. Witteveen, C. Coens, 2009, Annals of Oncology.

Severe Pelvic Floor Symptoms After Cervical Cancer Treatment Are Predominantly Associated With Mental and Physical Well-Being and Body Image: A Cross-Sectional Study

M. Sprangers, J. Roovers, J. Velden, 2012, International Journal of Gynecologic Cancer.